He serves as the Director for Perioperative Medicine, High Risk Cardiovascular Disease. Clinically, he specializes in pediatric and adult cardiothoracic anesthesiology, as well as in patients with complex cardiovascular disease presenting for noncardiac surgery (including patients with pulmonary hypertension, congenital heart disease, and endstage heart failure). His research focus is twofold, 1) the improvement of care for patients with congenital heart disease and pulmonary hypertension, 2) vascular biology – particular to elicit the underlying mechanisms involved in vascular stiffening.